Image may be NSFW.
Clik here to view.
Clik here to view.
OncoGenex starts Borealis-2 bladder cancer trial
OncoGenex Pharmaceuticals (NASDAQ:OGXI) has initiated the Borealis-2 clinical trial, an investigator-sponsored, randomized Phase 2 trial evaluating OGX-427 in combination with docetaxel in patients...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
CytRx awaiting soft tissue sarcoma data in December
What if it were possible to deliver a broad range of potent cancer drugs more optimally, enhancing both their safety and efficacy? That’s the question CytRx (NASDAQ:CYTR) hopes to answer this December...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Advaxis readies cervical cancer pivotal trial
Advaxis (NASDAQ:ADXS) hopes to begin a registration trial before the end of the year with its next-generation immunotherapy, ADXS-HPV, for the treatment of invasive cervical cancer. Daniel O’Connor “We...
View Article
More Pages to Explore .....
